Clinical Trial Update: An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated three dose levels of the SA3Ag Staphylococcus aureus vaccine in healthy adults and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infection

Drugs mentioned

• SA3Ag Staphylococcus aureus vaccine (SA3Ag)

Snippet

Sponsor: Pfizer | Conditions: Bacterial Infections, Staphylococcal Vaccines | Phase 1 | Status: COMPLETED